Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection

Sara Baldelli, Stefania Zenoni, Simona Merlini, Norberto Perico, Dario Cattaneo

Research output: Contribution to journalArticlepeer-review

Abstract

In the clinical practice of organ transplantation everolimus (RAD) is used in combination with cyclosporine (CsA), the most common antirejection agent. Both drugs show a narrow therapeutic window, which requires strict monitoring of their blood concentration. Simple methods for simultaneous measurement of RAD and CsA concentration are needed. As we have recently developed an HPLC-UV assay for RAD determination, we decided to implement it to allow concomitant measurement of CsA. The within- and between-day coefficients of variation of the measurement were less than 12.1% for RAD and 9.8% for CsA. The within- and between-day inaccuracy of quality control samples were less than 9.7% for RAD and less than 4.9% for CsA. The method was found accurate and precise and useful for simultaneous therapeutic monitoring of the two drugs.

Original languageEnglish
Pages (from-to)354-358
Number of pages5
JournalClinica Chimica Acta
Volume364
Issue number1-2
DOIs
Publication statusPublished - Feb 2006

Keywords

  • Cyclosporine
  • Everolimus
  • HPLC
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection'. Together they form a unique fingerprint.

Cite this